{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:29:58Z","timestamp":1780378198719,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":721,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","award":["IG2013\u2010JP"],"award-info":[{"award-number":["IG2013\u2010JP"]}],"id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1111\/ajt.16066","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T18:02:35Z","timestamp":1589911355000},"page":"3509-3519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9581-3682","authenticated-orcid":false,"given":"Curtis","family":"Mabilangan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-5582","authenticated-orcid":false,"given":"Catherine","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-4805","authenticated-orcid":false,"given":"Susan","family":"Nahirniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-2789","authenticated-orcid":false,"given":"Sheila","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0481-9692","authenticated-orcid":false,"given":"Jutta","family":"Preiksaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1111\/ajt.16066_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/infdis\/166.6.1236","article-title":"Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from yiremic patients","volume":"166","author":"Gerna","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1111\/ajt.16066_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/infdis\/jix069","article-title":"Determination of the biological form of human cytomegalovirus DNA in the plasma of solid-organ transplant recipients","volume":"215","author":"Tong","year":"2017","journal-title":"J Infect Dis."},{"issue":"11","key":"10.1111\/ajt.16066_bib3","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1537-2995.2007.01420.x","article-title":"High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion","volume":"47","author":"Ziemann","year":"2007","journal-title":"Transfusion."},{"issue":"1","key":"10.1111\/ajt.16066_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1423-0410.2009.01306.x","article-title":"The natural course of primary cytomegalovirus infection in blood donors","volume":"99","author":"Ziemann","year":"2010","journal-title":"Vox Sang."},{"issue":"3","key":"10.1111\/ajt.16066_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2007.11.014","article-title":"Human cytomegalovirus: latency and reactivation in the myeloid lineage","volume":"41","author":"Sinclair","year":"2008","journal-title":"J Clin Virol."},{"issue":"1","key":"10.1111\/ajt.16066_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0887-7963(91)70189-2","article-title":"Indications for the use of cytomegalovirus-seronegative blood products","volume":"5","author":"Preiksaitis","year":"1991","journal-title":"Transfus Med Rev."},{"issue":"3","key":"10.1111\/ajt.16066_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1537-2995.2003.00373.x","article-title":"Prevention of transfusion-acquired CMV infection: is there a role for NAT?","volume":"43","author":"Preiksaitis","year":"2003","journal-title":"Transfusion."},{"issue":"2","key":"10.1111\/ajt.16066_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biologicals.2009.01.002","article-title":"Transfusion-transmitted infectious diseases","volume":"37","author":"Allain","year":"2009","journal-title":"Biologicals."},{"issue":"3","key":"10.1111\/ajt.16066_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tmrv.2005.02.002","article-title":"Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis","volume":"19","author":"Vamvakas","year":"2005","journal-title":"Transfus Med Rev."},{"issue":"6","key":"10.1111\/ajt.16066_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/trf.13478","article-title":"Reducing the risk of transfusion-transmitted cytomegalovirus infection: a systematic review and meta-analysis","volume":"56","author":"Mainou","year":"2016","journal-title":"Transfusion."},{"issue":"6","key":"10.1111\/ajt.16066_bib11","first-page":"1581","article-title":"AABB committee report: reducing transfusion-transmitted cytomegalovirus infections","volume":"56","author":"Heddle","year":"2016","journal-title":"Transfusion."},{"issue":"5","key":"10.1111\/ajt.16066_bib12","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Science in medicine cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J Clin Invest."},{"issue":"4","key":"10.1111\/ajt.16066_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1525-1438.2002.00069.x","article-title":"The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center","volume":"42","author":"Preiksaitis","year":"2002","journal-title":"Transfusion."},{"issue":"7","key":"10.1111\/ajt.16066_bib14","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JCM.41.7.3167-3174.2003","article-title":"Comparison of LightCycler-based PCR, COBAS Amplicor CMV Monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation","volume":"41","author":"Pang","year":"2003","journal-title":"J Clin Microbiol."},{"issue":"1","key":"10.1111\/ajt.16066_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1111\/ajt.16066_bib16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1600-6143.2005.00866.x","article-title":"A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16066_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.16066_bib18","series-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"issue":"12","key":"10.1111\/ajt.16066_bib19","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1537-2995.2011.03203.x","article-title":"Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME)","volume":"51","author":"Thiele","year":"2011","journal-title":"Transfusion."},{"issue":"10","key":"10.1111\/ajt.16066_bib20","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1111\/j.1537-2995.2012.03739.x","article-title":"Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients","volume":"52","author":"Nash","year":"2012","journal-title":"Transfusion."},{"issue":"6","key":"10.1111\/ajt.16066_bib21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/tme.12219","article-title":"Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience","volume":"25","author":"Hall","year":"2015","journal-title":"Transfus Med."},{"issue":"10","key":"10.1111\/ajt.16066_bib22","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/trf.15456","article-title":"Prevention of transfusion-transmitted cytomegalovirus infection using leukoreduced blood components in patients receiving seronegative umbilical cord blood transplantation","volume":"59","author":"Shigemura","year":"2019","journal-title":"Transfusion."},{"issue":"12","key":"10.1111\/ajt.16066_bib23","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.bbmt.2013.09.013","article-title":"Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?","volume":"19","author":"Kekre","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"10.1111\/ajt.16066_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/vox.12250","article-title":"The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components","volume":"109","author":"Seed","year":"2015","journal-title":"Vox Sang."},{"issue":"3","key":"10.1111\/ajt.16066_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/vox.12103","article-title":"Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: standards of care","volume":"107","author":"Lieberman","year":"2014","journal-title":"Vox Sang."},{"key":"10.1111\/ajt.16066_bib26","unstructured":"Nahirniak S, Liebermann L, Preiksaitis J, Wall D. NAC Education Document: Transfusion and Cytomegalovirus in the Canadian Blood System. https:\/\/www.nacblood.ca\/resources\/guidelines\/downloads\/NAC_CMV_position_paper.pdf. Published 2017. Accessed March 14, 2019"},{"issue":"12","key":"10.1111\/ajt.16066_bib27","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.5858\/arpa.2016-0461-OA","article-title":"Survey on transfusion-transmitted cytomegalovirus and cytomegalovirus disease mitigation","volume":"141","author":"Weisberg","year":"2017","journal-title":"Arch Pathol Lab Med."},{"issue":"6","key":"10.1111\/ajt.16066_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The Third International Consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation."},{"issue":"23","key":"10.1111\/ajt.16066_bib29","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1073\/pnas.1704809114","article-title":"The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus","volume":"114","author":"Murrell","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"issue":"10","key":"10.1111\/ajt.16066_bib30","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/trf.12390","article-title":"Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors","volume":"53","author":"Furui","year":"2013","journal-title":"Transfusion."},{"issue":"10","key":"10.1111\/ajt.16066_bib31","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1111\/trf.12199","article-title":"The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients","volume":"53","author":"Ziemann","year":"2013","journal-title":"Transfusion."},{"issue":"10","key":"10.1111\/ajt.16066_bib32","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/JCM.01091-15","article-title":"Systematic evaluation of different nucleic acid amplification assays for cytomegalovirus detection: feasibility of blood donor screening","volume":"53","author":"Vollmer","year":"2015","journal-title":"J Clin Microbiol."},{"key":"10.1111\/ajt.16066_bib33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fimmu.2017.00733","article-title":"Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells","volume":"8","author":"Jackson","year":"2017","journal-title":"Front Immunol."},{"issue":"5","key":"10.1111\/ajt.16066_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol."},{"issue":"1","key":"10.1111\/ajt.16066_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0042-9007.2004.00388.x","article-title":"Continuous cytomegalovirus seroconversion in a large group of healthy blood donors","volume":"86","author":"Hecker","year":"2004","journal-title":"Vox Sang."},{"key":"10.1111\/ajt.16066_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fped.2016.00093","article-title":"Associations between EBV and CMV seropositivity, early exposures, and gut microbiota in a prospective birth cohort: a 10-year follow-up","volume":"4","author":"Carvalho-Queiroz","year":"2016","journal-title":"Front Pediatr."},{"issue":"1","key":"10.1111\/ajt.16066_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(87)80284-6","article-title":"Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study","volume":"110","author":"Yow","year":"1987","journal-title":"J Pediatr."},{"issue":"1","key":"10.1111\/ajt.16066_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pai.12030","article-title":"Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non-anthroposophic lifestyle - the ALADDIN birth cohort","volume":"24","author":"Hesla","year":"2013","journal-title":"Pediatr Allergy Immunol."},{"issue":"6","key":"10.1111\/ajt.16066_bib39","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/JCM.02172-08","article-title":"Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays","volume":"47","author":"Lagrou","year":"2009","journal-title":"J Clin Microbiol."},{"issue":"10","key":"10.1111\/ajt.16066_bib40","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/TP.0000000000001825","article-title":"CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor","volume":"101","author":"Schachtner","year":"2017","journal-title":"Transplantation."},{"issue":"11","key":"10.1111\/ajt.16066_bib41","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/cid\/ciu589","article-title":"Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients","volume":"59","author":"L\u00facia","year":"2014","journal-title":"Clin Infect Dis."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.16066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16066","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522216311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522216311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:28:54Z","timestamp":1761629334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522216311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1600613522216311"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16066","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}